EDNRB gene, several mutations have been reported; these are mostly private mutations located throughout the protein [Pingault et al., 2010] . The SOX10 gene (OMIM 602229) was also recognized as a SWS gene, responsible for the autosomal dominant form [Pingault et al., 1998 ]. It encodes the SRY-box 10 transcription factor involved in neural crest development. Mutations in this gene are also associated with a severe phenotype: PCWH syndrome (peripheral demyelinating neuropathy, central dysmyelinating leucodystrophy, Waardenburg syndrome, Hirschsprung disease) [Inoue et al., 1999 [Inoue et al., , 2004 Pingault et al., 2000; Touraine et al., 2000] .
Here, we describe a Morrocan patient with typical features of SWS who carries a novel mutation in the EDNRB gene.
Case Report
The propositus (VI-1) is the first child of healthy Moroccan consanguineous parents. She had 3 cousins who deceased at an early age with Hirschsprung disease and pigmentary anomalies (V-10, V-12 and V-13) ( fig. 1 ). Eight members of the family have pigmentation abnormalities of the iris (III-4, III-6, IV-2, IV-7, IV-11, IV-14, IV-15, IV-16), 2 relatives have white forelocks (V-14, V-16) and 5 have a combination of both features ( fig. 1 ). Pregnancy and delivery were normal, and the child was born at term with normal physical measurements at birth. There was a failure to pass meconium within the first 48 h. Hirschsprung disease was confirmed and a colostomy was performed.
At the clinical examination, the proband was 3 months old with no dysmorphic features. The measurements were within the normal range: weight 5,200 g (30th percentile), height 59 cm (50th percentile) and OFC 38 cm (10th percentile). She had a frontal white forelock, an iris pigmentation abnormality with hypoplastic blue eyes and hypopigmented areas on the right forearm and the right lower limb. Both of the parents were normal on clinical examination.
The auditory evoked potential recorded at the age of 6 months objectified a bilateral profound sensorineural hearing loss requiring cochlear implant. At ophthalmological examination, the proband showed a depigmented retina. The temporal bone computed tomography revealed a subtotal filling of the hypotympanum and mesotympanum dishing in the external auditory meatus, thick appearance of the tympanic membrane respecting the wall of the stall and partial filling of the other mastoid. The cerebral MRI was normal. Based on these clinical findings, WS type IV was suspected. Informed consent was obtained from the proband's parents prior to genetic testing. Peripheral blood samples were collected from the affected child and her parents. DNA was extracted by standard methods.
To search for point mutations, the coding exons of EDN3, EDNRB and SOX10 genes were analyzed by direct sequencing of the PCR products using the Sanger method. Quantitative multiplex fluorescent (QMF) PCR was used to detect rearrangements and copy number variants. SOX10 was analyzed as previously described [Pingault et al., 2013] , while the EDN3 and EDNRB genes were amplified using the primers listed in table 1 . This led to the identification of a homozygous nucleotide substitution within exon 6 of the EDNRB gene, c.1133A>G (Chromosome 13: 77899920), as the sole putative causative variation. This variation predicts the replacement of asparagine by a serine at amino acid position 378 of the protein (p.Asn378Ser), which is located in the 7th helical transmembrane domain. The parents carried the same variant in a heterozygous state ( fig. 2 ) . Samples of the deceased cousins were not available, so we tested their parents who were shown to be also heterozygous for this mutation. The variant was not found in the 1000 Genomes database (http:// www.1000genomes.org/), nor in the Exome Variant Server (http:// evs.gs.washington.edu/EVS/). Finally, we excluded the possibility that it is a frequent polymorphism in Morocco by screening 200 Morrocan control chromosomes for this nucleotide substitution by real-time PCR (StepOne TM Real-Time PCR System) using TaqMan ® probes.
In silico Analysis
Effects of the sequence variation were predicted by using the PROVEAN [Choi et al., 2012] , PolyPhen-2 [Adzhubei et al., 2010] and SIFT [Ng and Henikoff, 2001] web-based platforms. PolyPhen-2 suggested that the Asn378Ser mutation was 'probably damaging', the SIFT algorithm and PROVEAN considered the mutation as damaging and deleterious, respectively. The Grantham matrix score for Asn → Ser is 65 [Grantham, 1974] .
Discussion
SWS is defined by the association of pigmentary abnormalities involving skin, eyes and/or hair, sensorineural deafness and Hirschsprung disease [Shah et al., 1981] . Its prevalence is low, but not precisely defined (1/40,000 for WS as a whole), and about 50 cases have been reported in Europe (http://www.orpha.net/orphacom/cahiers/ docs/GB/Prevalence_of_rare_diseases_by_alphabetical_ list.pdf). This congenital developmental disorder is clini- [Pingault et al., 2010] . Mutations in EDNRB or EDN3 genes are found in 20-30% of SWS patients.
The EDNRB gene, located in 13q22.3, spans 24 kb and comprises 7 exons. Each intron occurs near the border of the putative transmembrane domain in the coding region [Arai et al., 1993] . Until December 2013, 24 EDNRB mutations were reported to be associated with SWS (http:// grenada.lumc.nl/LOVD2/WS), and they are located throughout the protein. About half of them are missense mutations, the rest being truncating mutations or fullgene deletions. In the present report, we identified a homozygous variant within exon 6 of the EDNRB gene where the adenine was replaced by guanine (c.1133A>G). This change leads to the substitution of the asparagine-378 residue with a serine residue, and it is located in the 7th transmembrane domain of the endothelin B receptor. Asparagine 378 is fully conserved between species, as well as between type A and type B endothelin receptors ( fig. 3 ). This amino acid substitution does not change the charge or polarity, but replaces a hydroxyl by an amine group. As very few functional tests have been performed so far on this protein, it is difficult to predict whether this specific change destabilizes the transmembrane domain or impairs its function. According to the few references, a discussion on this subject would be very speculative for this mutation. The combined observation of its absence in 200 Moroccan control chromosomes and of its linkage with the disease in a distinct branch of the family strongly suggests that this missense change is the causative mutation in this family.
For the EDNRB (as well as EDN3 ) gene mutations, there is no obvious phenotype-genotype correlation. Most mutations are private with intra-and interfamilial variability [Pingault et al., 2010] . Individuals carrying homozygous mutations have SWS, while individuals with heterozygous mutations in the same family may either be asymptomatic or have some features of the disease. In the present report, the family members with pigmentary disturbances are likely heterozygous, as it is the case for the cousins' father (IV-7) and for several obligate carriers of the mutation (IV-5, IV-11). Then, the disease in this family appears as semi-dominant (mild phenotype with incomplete penetrance in heterozygotes, severe disease in homozygotes). The influence of modifier genes has been proposed to explain the phenotypic variability in WS, and may be more sensitive or visible in heterozygous individuals than in homozygotes in this family.
The diagnosis of SWS is mainly clinical. Molecular diagnosis is especially important for genetic counseling which should be adapted to the mode of transmission associated with the detected mutation. There is neither available data about the frequency of WS in Morocco nor in the Arab world. The prevalence of the autosomal recessive forms might be higher in Morocco than in developed countries, which can be explained by the high rate of consanguinity (15.25%) [Jaouad et al., 2009] . Parental consanguinity may increase the risk for SWS, and genetic counseling for families with such patients is important to prevent consanguineous marriages and consequently reduce the occurrence of SWS in these families.
In addition to SWS, mutations in the EDNRB gene are involved in susceptibility to Hirschsprung disease (mostly heterozygous). A homozygous mutation has also been reported in the ABCD syndrome with partial albinism, black lock, cell migration disorder of the neurocytes of the gut, and deafness. This autosomal recessive neural crest syndrome has a clinical phenotype strongly overlapping with SWS, suggesting that ABCD syndrome is not a separate entity, but an expression of SWS (the main difference being the extent of the depigmentation) [Verheij et al., 2002] .
Heterozygous proximal 13q deletions (including EDNRB ) have also been reported [Tüysüz et al., 2009] . In addition to common features seen in SWS, the 13q deletion syndrome includes hypertelorism and epicanthus with developmental delay.
Prenatal molecular diagnosis can be offered if the disease-causing mutation has been identified in the family. Given the clinical variability even within families, this testing is rarely requested, but it could be proposed for severe cases with homozygous forms of EDN3 and EDNRB mutations in which the prognosis is not always favorable.
To the best of our knowledge, among the cases in the Arab world, only 1 Lebanese family with SWS has been studied with molecular techniques and was found to carry a novel mutation in the EDNRB gene [Haddad et al., 2011] . We believe that the report of mutations in the genes involved in SWS is important and will help in the further delineation of the clinical and molecular spectrum in order to define genotype-phenotype correlations.
